Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 03 May 2024 11:42:29 +0200Tue, 23 Jan 2024 11:44:00 +0100Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/mavencladHuman medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/mavencladTue, 23 Jan 2024 11:44:00 +0100Human medicineMavenclad : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500234562_en.pdfMavenclad : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500234562_en.pdfFri, 08 Sep 2017 02:00:00 +0200Human medicine